Literature DB >> 8387902

Bioequivalence of conjugated estrogen products.

R Ansbacher1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8387902     DOI： 10.2165/00003088-199324040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  2 in total

1.  Generic drugs: bioequivalence and bioavailability.

Authors:  R Ansbacher
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

2.  17 beta-estradiol for postmenopausal estrogen replacement therapy.

Authors:  K C Nichols; L Schenkel; H Benson
Journal:  Obstet Gynecol Surv       Date:  1984-04       Impact factor: 2.347
  2 in total
  2 in total

Review 1.  Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

Authors:  R Whittington; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

Review 2.  Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

Authors:  R Whittington; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.